Suzhou Nongfa Innovation Capital Management
Overview
Suzhou Nongfa Innovation Capital Management is an investment firm focused on supporting agricultural technology innovation and the transformation of scientific and technological achievements, operating as a subsidiary of the Suzhou Agriculture Development Group.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Changingtek Robotics | Dec 2020 | Series A | Co-investor |
| Suzhou Big Vision Medical Technology Co., Ltd. | Dec 2021 | Series A Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Suzhou Nongfa Innovation Capital Management based?
Suzhou Nongfa Innovation Capital Management is headquartered in Suzhou, China.
When was Suzhou Nongfa Innovation Capital Management founded?
Suzhou Nongfa Innovation Capital Management was founded in 2011.
How many portfolio companies does Suzhou Nongfa Innovation Capital Management have?
Suzhou Nongfa Innovation Capital Management has 2 portfolio companies in Caplight's dataset.
What are some companies in Suzhou Nongfa Innovation Capital Management's portfolio?
Portfolio companies visible on Caplight include Changingtek Robotics, Suzhou Big Vision Medical Technology Co., Ltd..
What was Suzhou Nongfa Innovation Capital Management's most recent investment shown here?
Suzhou Nongfa Innovation Capital Management's most recent investment in this portfolio sample was in Suzhou Big Vision Medical Technology Co., Ltd. in 2021.
What sectors does Suzhou Nongfa Innovation Capital Management focus on?
Suzhou Nongfa Innovation Capital Management focuses on Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Mobility, Transportation & Logistics.
What company stages does Suzhou Nongfa Innovation Capital Management focus on?
Suzhou Nongfa Innovation Capital Management typically invests at the Early stage.
What is Suzhou Nongfa Innovation Capital Management's AUM?
Suzhou Nongfa Innovation Capital Management's assets under management are estimated between $82.2M and $274.0M.